TOP NEWS: GSK to buy Aiolos Bio for up to USD1.4 billion
(Alliance News) - GSK PLC on Tuesday said it will acquire asthma drug developer Aiolos Bio Inc for USD1 billion upfront, as well as up to USD400 million in certain success-based milestone payments. Read More